Cargando…

Gas6/TAM Receptors in Systemic Lupus Erythematosus

Systemic lupus erythematosus (SLE) is a multiorgan autoimmune disease associated with impaired immune system regulation. The exact mechanisms of SLE development remain to be elucidated. TAM receptor tyrosine kinases (RTKs) are important for apoptotic cell clearance, immune homeostasis, and resolutio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cohen, Philip L., Shao, Wen-Hai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6652053/ https://www.ncbi.nlm.nih.gov/pubmed/31360267 http://dx.doi.org/10.1155/2019/7838195

Ejemplares similares

TAM receptor ligands in lupus: Protein S but not Gas6 levels reflect disease activity in systemic lupus erythematosus
por: Suh, Chang-Hee, et al.
Publicado: (2010)

Disturbances of apoptotic cell clearance in systemic lupus erythematosus
por: Shao, Wen-Hai, et al.
Publicado: (2011)

The Gas6/TAM System and Multiple Sclerosis
por: Bellan, Mattia, et al.
Publicado: (2016)

Vitamin K-dependent proteins GAS6 and Protein S and TAM receptors in patients of systemic lupus erythematosus: correlation with common genetic variants and disease activity
por: Recarte-Pelz, Pedro, et al.
Publicado: (2013)

Correction: Vitamin K-dependent proteins GAS6 and Protein S and TAM receptors in patients of systemic lupus erythematosus: correlation with common genetic variants and disease activity
por: Recarte-Pelz, Pedro, et al.
Publicado: (2014)

Targeting Gas6/TAM in cancer cells and tumor microenvironment
por: Wu, Guiling, et al.
Publicado: (2018)

Molecular insights of Gas6/TAM in cancer development and therapy
por: Wu, Guiling, et al.
Publicado: (2017)

Growth Arrest-Specific 6 (Gas6) and TAM Receptors in Mouse Platelets
por: Uras, Fikriye, et al.
Publicado: (2015)

Gas6/TAM System: A Key Modulator of the Interplay between Inflammation and Fibrosis
por: Bellan, Mattia, et al.
Publicado: (2019)

TAM receptors, Phosphatidylserine, inflammation, and Cancer
por: Burstyn-Cohen, Tal, et al.
Publicado: (2019)

Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis
por: Smirne, Carlo, et al.
Publicado: (2019)

Epigenetic Alterations in Immune Cells of Systemic Lupus Erythematosus and Therapeutic Implications
por: Adams, David E., et al.
Publicado: (2022)

GAS6/TAM Pathway Signaling in Hemostasis and Thrombosis
por: Law, Luke A., et al.
Publicado: (2018)

Role of Gas6 and TAM Receptors in the Identification of Cardiopulmonary Involvement in Systemic Sclerosis and Scleroderma Spectrum Disorders
por: Bellan, Mattia, et al.
Publicado: (2020)

Regulation of cGAS-STING Pathway - Implications for Systemic Lupus Erythematosus
por: Hagiwara, Audrey M., et al.
Publicado: (2021)

Gas6/TAM Axis Involvement in Modulating Inflammation and Fibrosis in COVID-19 Patients
por: Rizzi, Manuela, et al.
Publicado: (2023)

Targeting the TAM Receptors in Leukemia
por: Huey, Madeline G., et al.
Publicado: (2016)

Systemic lupus erythematosus
por: Manson, Jessica J, et al.
Publicado: (2006)

TAM Receptor Inhibition–Implications for Cancer and the Immune System
por: Aehnlich, Pia, et al.
Publicado: (2021)

Role of the Gas6/TAM System as a Disease Marker and Potential Drug Target
por: Sainaghi, Pier Paolo, et al.
Publicado: (2021)

TAM-ing T cells in the tumor microenvironment: implications for TAM receptor targeting
por: Peeters, Marlies J. W., et al.
Publicado: (2019)

Systemic Lupus Erythematosus Presenting as Alopecia Areata
por: Forouzan, Parnia, et al.
Publicado: (2020)

TAM receptors in cardiovascular disease
por: McShane, Lucy, et al.
Publicado: (2019)

TAM Signaling in the Nervous System
por: Burstyn-Cohen, Tal, et al.
Publicado: (2021)

Systemic Lupus Erythematosus
por: Peng, Stanford
Publicado: (1993)

Immuno-oncology: are TAM receptors in glioblastoma friends or foes?
por: Zhou, Yunxiang, et al.
Publicado: (2021)

Small molecule inhibitors block Gas6-inducible TAM activation and tumorigenicity
por: Kimani, Stanley G., et al.
Publicado: (2017)

Complement and systemic lupus erythematosus
por: Walport, Mark J
Publicado: (2002)

Systemic lupus erythematosus and thrombosis
por: Bazzan, Mario, et al.
Publicado: (2015)

Systemic Lupus Erythematosus and Immunodeficiency
por: Chan, Shirley Chiu Wai, et al.
Publicado: (2021)

Plasma concentrations of Gas6 and sAxl correlate with disease activity in systemic lupus erythematosus
por: Ekman, Carl, et al.
Publicado: (2011)

Systemic Lupus Erythematosus Management in Pregnancy
por: Dao, Kathryn H, et al.
Publicado: (2022)

Gas6/TAM Axis in Sepsis: Time to Consider Its Potential Role as a Therapeutic Target
por: Salmi, Livia, et al.
Publicado: (2019)

Are Toll-Like Receptors and Decoy Receptors Involved in the Immunopathogenesis of Systemic Lupus Erythematosus and Lupus-Like Syndromes?
por: Guggino, Giuliana, et al.
Publicado: (2012)

Bullous systemic lupus erythematosus in females
por: Sprow, Grant, et al.
Publicado: (2022)

The lupus band test in systemic lupus erythematosus patients
por: Reich, Adam, et al.
Publicado: (2011)

Advancing understanding, diagnosis, and therapies for cutaneous lupus erythematosus within the broader context of systemic lupus erythematosus
por: Chen, Kristen L., et al.
Publicado: (2019)

Cutaneous Manifestations of “Lupus”: Systemic Lupus Erythematosus and Beyond
por: Cooper, Elizabeth E., et al.
Publicado: (2021)

Toll-like receptors and innate immune responses in systemic lupus erythematosus
por: Lafyatis, Robert, et al.
Publicado: (2007)

TAM Receptor Pathways at the Crossroads of Neuroinflammation and Neurodegeneration
por: Tondo, Giacomo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hsheo0lvptrmmbstloittja427